The damage can lead to both sudden “flares” of inflammation and a slow worsening of symptoms over time. Historically, MS has ...
LISCure Biosciences ("LISCure"), a clinical-stage biopharmaceutical company, announced the initiation of patient dosing in a global Phase 2 clinical trial of LB-P8, a novel therapeutic candidate for ...
Beauty businesses are being encouraged to join a scheme which demonstrates safe standards for customers considering procedures such as Botox, cosmetic fillers or chemical peels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback